Het effect van galantamine op de ecg- geleidingstijden
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cummings JL. Use of cholinesterase inhibitors in clinical practice. Evidence – based recommendations. Am J Geriatr Psychiatry 2003; 11; 131–145
Masuda Y, Kawamura. Acetylcholinesterase inhibitor (Donepezil Hydrochloride) reduces heart rate variability. Journal of cardiovascular pharmacology. 41 (suppl.1): S67-S71
Leitch A, McGinness P, Wallbridge D. Calculate the QT interval in patients taking drugs for dementia BMJ. 2007;335(7619):557.
Suleyman T, Tevfik P, Abdulkadir G et al. Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J. 2006;23 (8):641–2
Leentjens AF, Kragten JA. Complete atrioventricular block during galantamine therapy. Ned Tijdschr Geneeskd. 2006;150 (10):563–6
Bordier P, Garrigue S, Lanusse S et al. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer’s disease. CNS Drugs 2006;20 (5): 411–417
Doody RS, Corey–Bloom J, Zhang R. Safety and tolerability of donepezil at doses up to 20 mg/ day. Results from a pilot study in patients with Alzheimer’s disease. Drugs Aging 2008: 25 (2): 163–174.
Boada-Rovira M, Brodaty H, Cras P et al. Efficacy and safety of donepezil in Alzheimer’s disease. Drugs Aging 2004;21 (1):43–53.
Fisher AA, Davis MW. Prolonged QT interval, syncope, and delirium with galantamine. The Annals of Pharmacotherapy. 2008;42 (2):278–83
Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane database syst. Rev. 2006;(1): CD005593
Gill S.S, Anderson GM, Fischer HD et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors. A population-based cohort study. Arch Intern Med. 2009;169 (9):867–73
Hernandez RK, Farwell W, Cantor MD et al. Cholinesterase Inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs New England healthcare system. J Am Geriatr Soc 2009 57 (11); 1997–2003.
Morganroth J, Graham S, Hartman R. Electrocardiographic effects of rivastigmine. J Clin Pharmacol. 2002;42(5):558–68
Isik AT, Bozoglu E, Naharci MI et al. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer’s disease. Am J Geriatr Pharmacother. 2010; 8 (5):454–9.
Isik AT, Yildiz GB, Bozoglu E. Cardiac safety of donepezil in elderly patients with Alzheimer disease. Intern Med. 2012; 51(6):575–8.
Isik AT, Bozoglu E. Yay A. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2012; 27(3):171–4.